X

Sakar Healthcare Ltd Stock Analysis

Small Cap
Evaluated by 55 users | BSE: 0 | NSE: SAKAR |
Pharmaceuticals & Drugs
Having a vision to make lives healthy, happy and more meaningful by providing healthcare solutions, Sakar Healthcare Limited, was incorporated on March 26, 2004. Subsequently, the company was converted into a public limited company and a fresh Certificate of Incorporation consequent upon...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 8.44%10.06%11.32%10.1%11.53%11.19%8.97%11.03%11.72%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 16.221.929.73541.244.253.168.383
Y-o-Y Gr. Rt.-35.3%35.5%18%17.7%7.1%20.2%28.6%21.6%
Adjusted EPS (Rs.) 1.241.812.192.32.913.043.034.436.03
Y-o-Y Gr. Rt.-46%21%5%26.5%4.5%-0.3%46.2%36.1%
Book Value per Share (Rs.) 12.2414.0516.2418.5321.4532.3938.3447.9554.35
Adjusted Net Profit 11.51.81.82.33.33.76.69
Net Op. Cash Flow (Rs. Cr.) 11.46.68.64.29.29.25.316.110.1
Debt to Cash Flow from Ops 2.854.082.845.932.12.312.760.691.65
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Sakar Healthcare Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales NA18.8%23.4%21.6%
Adjusted EPS NA21.3%25.7%36.1%
Book Value per Share 02418.813.4
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 9.2912.6813.4812.814.5612.678.4910.7511.78
Operating Profit Margin (%) 43.3334.426.3622.4720.2423.0123.6924.7123.56
Net Profit Margin (%) 6.126.65.95.245.657.556.969.710.87
Debt to Equity 3.312.41.871.671.130.60.310.160.21
Working Capital Days 0193164142118144167140134
Cash Conversion Cycle 07154655454615653
Entity Percentage Holding
Promoters 72.88%
Non-Institutions 27.12%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Having a vision to make lives healthy, happy and more meaningful by providing healthcare solutions, Sakar Healthcare Limited, was incorporated on March 26, 2004. Subsequently, the company was converted into a public limited company and a fresh Certificate of Incorporation consequent upon change of name on Conversion to Public Limited Company dated March 27, 2015 was issued by the Registrar of Companies, Gujarat, Ahmedabad and the name of the company has got changed to 'Sakar

Having a vision to make lives healthy, happy and more meaningful by providing healthcare solutions, Sakar Healthcare Limited, was incorporated on March 26, 2004. Subsequently, the company was converted into a public limited company and a fresh Certificate of Incorporation consequent upon change of name on Conversion to Public Limited Company dated March 27, 2015 was issued by the Registrar of Companies, Gujarat, Ahmedabad and the name of the company has got changed to 'Sakar Healthcare Limited'.

The company is managed by a team of professionals headed by its Managing Director having experience in manufacturing and export of pharmaceutical and health care products to various countries. Its preliminary business area and key focus was in contract manufacturing in the past years. As a contract manufacturer, the company undertakes manufacturing on behalf of some of the leading pharmaceutical companies in India, in accordance with the terms of the relevant agreements entered into with these companies. The company has registered its products in various countries which are marketed through supply, distribution and other arrangements with various dealers / distributors.

The company’s manufacturing facilities are located at Changodar, Ahmedabad, Gujarat. Its facilities have been approved by various international regulatory authorities such as BVQI, WHO, GM:P, CGMP and National Drug Authority of various countries including Nigeria, Ethopia, Ghana, Bolivia, Yemen and Philippines, Uganda, Ivory Coast, etc.

Business area of the company

The company is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party. It also undertakes contract manufacturing of formulations for pharmaceutical companies based in India. It manufactures and markets pharmaceutical formulations relating to analgesics, antielminthics, anti coagulants, anti malarial, anti spasmodics, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

 

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback